Optometry Times now breaks news on Facebook, Twitter

Article

Optometry Times has established a presence on Twitter at www.twitter.com/Optometry Times and Facebook at www.facebook.com/OptometryTimes.

North Olmstead, OH-Optometry Times, the leading source of optometric news, has established a presence on Twitter at http://www.twitter.com/OptometryTimes and Facebook at http://www.facebook.com/OptometryTimes

"We've found there is so much happening in optometry and in the ophthalmic industry that we could not keep up with all of it with a print publication, Web site, and e-newsletter," said Rich Kirkner, editor-in-chief of Optometry Times

"Social media is giving us an opportunity to push out more news that's meaningful to optometrists more frequently than we could otherwise," Kirkner said.

"Our goal is to keep optometrists informed of the fast-paced changes that are buffeting the profession, and to give them the tools to adapt to those changes," Kirkner said. "Following Optometry Times on Twitter and liking us on Facebook are just two ways ODs can keep themselves better informed of those changes."

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.